Search Results 1101-1110 of 16089 for pharmacogenetics
Dr. Harris' Polycystic Kidney Disease Discovery Lab at Mayo Clinic focuses its ARPKD research on genotype and phenotype studies and on the role of ...
About this study. The purpose of this study is to collect data and biospecimens from patients experiencing or worsening neurological conditions associated ...
A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression.
To assess whether health promotion tools such as psychoeducation applied to non-distressed breast cancer patients will result in lower distress at 3, 6, 9 & 12 ...
The purpose of this study is to gain stepwise understanding of the fundamental biology governing human antitumor immunity, by systematic study of the tumor- ...
The research involved a new blood test developed by Mayo Clinic to identify women at higher genetic risk for developing breast cancer. "The practice-changing ...
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...
Get a closer look at our research process, learn about our lab's equipment, and explore microscopy images on myocarditis, fibrosis and pericardial inflammation ...
About this study. This protocol is being conducted to determine the mechanisms responsible for insulin resistance, obesity and type 2 diabetes.
An expert faculty guides research in the Mayo Clinic Division of Endocrinology, Diabetes, Metabolism, and Nutrition.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.